WallStSmart

Amkor Technology Inc (AMKR)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amkor Technology Inc generates 2631% more annual revenue ($7.07B vs $258.90M). AMKR leads profitability with a 6.2% profit margin vs -15.5%. AMKR earns a higher WallStSmart Score of 63/100 (C+).

AMKR

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 5.5Value: 4.7Quality: 7.0
Piotroski: 2/9Altman Z: 2.55

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMKRSignificantly Overvalued (-45.5%)

Margin of Safety

-45.5%

Fair Value

$38.60

Current Price

$69.75

$31.15 premium

UndervaluedFair: $38.60Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMKR3 strengths · Avg: 8.7/10
EPS GrowthGrowth
285.6%10/10

Earnings expanding 285.6% YoY

PEG RatioValuation
0.768/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

AMKR4 concerns · Avg: 2.5/10
Profit MarginProfitability
6.2%3/10

6.2% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
40.6x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-79.52M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : AMKR

The strongest argument for AMKR centers on EPS Growth, PEG Ratio, Revenue Growth. Revenue growth of 27.5% demonstrates continued momentum. PEG of 0.76 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : AMKR

The primary concerns for AMKR are Profit Margin, Piotroski F-Score, P/E Ratio. A P/E of 40.6x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

AMKR profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

AMKR carries more volatility with a beta of 1.95 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SEMICONDUCTOR EQUIPMENT & MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMKR scores higher overall (63/100 vs 41/100) and 27.5% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amkor Technology Inc

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

Amkor Technology, Inc. provides outsourced semiconductor packaging and testing services in the United States, Japan, Europe, the Middle East, Africa, and the rest of Asia Pacific. The company is headquartered in Tempe, Arizona.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?